Recent Events & Catalysts
Edgewise Therapeutics, Inc. (EWTX) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Goldman Sachs Maintains Neutral on Edgewise Therapeutics, Raises Price Target to $36
Benzinga · today
Edgewise Therapeutics Q2 EPS $(0.53) Misses $(0.47) Estimate
Benzinga · 5d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-06 · 5d ago · Material
Financial statements and exhibits
Filed 2026-07-16 · 26d ago
Completion of acquisition or disposition of assets, Regulation FD disclosure, Financial statements and exhibits
Filed 2026-07-13 · 29d ago · Material
Submission of matters to a vote of security holders
Filed 2026-06-05 · 67d ago
Entry into a material agreement, Financial statements and exhibits
Filed 2026-06-01 · 71d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.